The global bioimpedance analyzer market was valued at USD 570.80 million in 2024 and is anticipated to reach USD 1,479.14 million by 2034, growing at a CAGR of 10.0% over the forecast period. The market growth is primarily driven by the increasing focus on body composition analysis in clinical, wellness, and research settings, as well as rising...